Zydus Lifesciences is working to advance its position in the global pharmaceutical sector by increasing its focus on medical ...

Before serving as interim president at Caremark, DeVaney led ... formerly the CEO of value-based primary care company ChenMed, to lead CVS’ insurer Aetna. The unit’s previous head was removed ...

CVS could wind up as the only pharmacy stock in the U.S. if Walgreens goes private. But the drugstore chain, worth about $65 billion, could also become much smaller in the not-so-distant future.

That has spurred PBMs like CVS Caremark (CVS) to defend their companies' value in the overall healthcare system ... And if you think what their role is inside of the supply chain, they work every day ...

CVS Health CEO David Joyner ... rising healthcare costs is PBMs like Caremark," Joyner said. "These entities remain the only part of the drug supply chain and entirely focused on lowering costs ...

CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. DeVaney has served as interim president of Caremark since December 2024. The president's role was ...